CPT code 53260 represents excision or destruction of a urethral polyp, typically performed to improve urinary flow and relieve urethral pain. As a focused genitourinary surgical procedure, it is relevant across outpatient surgical settings and hospital outpatient departments. Nationally, accurate coding of this procedure affects clinical documentation, facility vs. professional billing determinations, and utilization monitoring for urologic benign lesions.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage policies and prior authorization requirements can vary by payer and site of service, affecting where and how the procedure is scheduled and reimbursed.

Readers will find benchmarks for use and billing patterns, summaries of payer policy themes, and clinical context that clarifies when 53260 is typically reported. The publication outlines typical sites of service, common clinical indications, and the role of this procedure within urologic care. Data not available in the input is noted where applicable.